Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/9/2018
SIETES contiene 92559 citas

 
 
 1 a 20 de 277 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med 2018:24 de julio. [Ref.ID 102748]
2.Tiene citas relacionadas Cita con resumen
Rasmussen SA, Barfield W, Honein MA. Protecting mothers and babies — A delicate balancing act. N Engl J Med 2018:24 de julio. [Ref.ID 102747]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Angus-Leppan H, Liu RSN. Weighing the risks of valproate in women who could become pregnant. BMJ 2018;361:18 de abril. [Ref.ID 102682]
6. Cita con resumen
Pennel PB. Prescribing antiepileptic drugs to women of reproductive age. Lancet Neurol 2018;17:485-6. [Ref.ID 102517]
7. Cita con resumen
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F, for the EURAP study group. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018;17:530-8. [Ref.ID 102516]
8. Cita con resumen
Pennell PB. Antiepileptic drugs in pregnancy — Quick decisions with long-term consequences. JAMA Neurology 2018;75:652-4. [Ref.ID 102464]
9. Cita con resumen
Elkjær LS, Bech BH, Sun Y, Laursen TM, Christensen J. Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children. JAMA Neurology 2018;75:663-71. [Ref.ID 102463]
10. Cita con resumen
Bjørk M, Riedel B, Spiqset O, Veiby G, Kolstad E, Daltveit AK, Gilhus NE. Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs In utero. JAMA Neurology 2017:26 de diciembre. [Ref.ID 102193]
11. Cita con resumen
Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 2017;318:1700-1. [Ref.ID 102140]
12. Cita con resumen
Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Tacconi FM. Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies. Br J Clin Pharmacol 2017;83:1873-9. [Ref.ID 102027]
13. Cita con resumen
Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Benedetto U. Tolerability of new antiepileptic drugs: a network meta-analysis. Eur J Clin Pharmacol 2017;73:811-7. [Ref.ID 101994]
14. Cita con resumen
Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernández-Díaz S. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 2017;376:2245-54. [Ref.ID 101629]
15. Cita con resumen
Anónimo. Pérampanel et épilepsies généralisées réfractaires. Prescrire 2016;36:492-3. [Ref.ID 100550]
16. Cita con resumen
Anónimo. Hyponatrémies d'origine médicamenteuse. Prescrire 2015;35:666-71. [Ref.ID 99717]
17. Cita con resumen
18. Cita con resumen
Velez-Ruiz NJ, Meador KJ. Neurodevelopmental effects of fetal antiepileptic drug exposure. Drug Saf 2015;38:271-8. [Ref.ID 98950]
19.Enlace a cita original
Ferrer P, Rafaniello C, Sabaté M, Ballarín E, Coma A, Zara C, Capuano A, Rossi F, Laporte JR, Ibáñez L. Cross-national comparison of antiepileptic drug use: Catalonia, Denmark and Norway, 2007-2011. Epidemiology Biostatistics and Public Health 2014;11:e9405-9409. [Ref.ID 98375]
20. Cita con resumen
Fazel S, Zeterqvist J, Larsson H, Langström N, Lichtenstein P. Antipsychotics, mood stabilisers, and risk of violent crime. Lancet 2014;384:1206-14. [Ref.ID 98115]
Seleccionar todas
 
 1 a 20 de 277 siguiente >>